Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

First-in-human results show safety and immunogenicity of a novel AIDS vaccine

Sep. 20, 2012

Mutabilis receives E.U. funding to support HIVINNOV project for new antiretrovirals

Sep. 19, 2012

GeoVax presents promising phase II results for their HIV vaccines

Sep. 17, 2012

First-in-human results presented for a novel anti-HIV-1 vaccine

Sep. 14, 2012

Frontier Biotechnologies presents early clinical data for albuvirtide

Sep. 13, 2012

Transgene Biotek patents novel fusion proteins for HIV

Sep. 12, 2012

Bristol-Myers Squibb patents new agents for HIV

Sep. 4, 2012

Novel candidate HIV medicines presented by Bristol-Myers Squibb

Aug. 29, 2012

FDA approves new combination pill for HIV

Aug. 28, 2012

NIH awards HIV vaccine research grants

Aug. 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...